University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 25 of 26
Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
NCT01608906
Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
NCT00477204
A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
NCT00482963
Parent Perceptions of Weight Status: Impact of a Pilot Intervention
NCT00867373
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
NCT00478335
Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)
NCT01542736
Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
NCT00478036
Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy
NCT00452283
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT00608062
Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas
NCT00822887
Examining Macrophage Influx and Vascularization in Chronic Pancreatitis
NCT00491023
Pilot Study of Human Tear Proteins
NCT00453258
Analysis of Human Tear Proteins in Children
NCT00473278
Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)
NCT00419380
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
NCT00414518
Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
NCT00955487
Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes
NCT00454025
Salvage Cryotherapy in Recurrent Prostate Cancer
NCT00824928
Pramlintide in Adolescents With Type 1 Diabetes
NCT00842075
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT00456365
Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
NCT00430027
Development of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation
NCT00835302
Genetics and HIV-1 Protease Inhibitors
NCT01388543
Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado
NCT01044927
Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors
NCT00361673
The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer
NCT00487721
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
NCT00353301
Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
NCT00332124
Acetaminophen and Impaired Musculoskeletal Adaptations to Exercise Training
NCT01083901
Martial Arts as Early Intervention for Teen Drug Abuse
NCT00956527
RCT of Mailed Brochure to Boost Adherence to Screening Colonoscopy
NCT00308568
Vitamin D Levels and Vitamin D Education in Geriatric Patients
NCT00273611
Pilot Study of Haloperidol to Treat Critical Illness Delirium
NCT00429676
A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
NCT00792012
Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults
NCT00255944
Using Learning Teams for Reflective Adaptation for Diabetes and Depression
NCT00414986
Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
NCT00552734
The Effects of Energy Imbalance on Food Intake Behaviors
NCT03112161
A Study to Examine Health Behavior Change Strategies for Primary Care
NCT01323023
Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump
NCT00884650
The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
NCT01832766
Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics
NCT01386970
Telephone Support Intervention to Improve Breastfeeding
NCT00717496
Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.
NCT00249938
Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
NCT00149734
Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
NCT00100165
TEAM: Testosterone Supplementation and Exercise in Elderly Men
NCT00112151
Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
NCT00364221
HIV and HCV Intervention In Drug Treatment Settings - 1
NCT00102349
Immobilization in External Rotation After First Time Anterior Shoulder Dislocation
NCT00707018
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.